Search research articles
Contact Us
Filters
Showing results (11-20 of 50) with videos related to
Page
of 5
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 30, 2025
C/EBPβ stabilizes oxidative stress in triple-negative breast cancer cells, driving taxane resistance and immune evasion
Kevin Holm, Min-Sun Song, L Z Samara, et al.
Molecular Therapy. Nucleic Acids
|
December 2, 2024
Local CpG-<i>Stat3</i> siRNA treatment improves antitumor effects of immune checkpoint inhibitors
Chunyan Zhang, Rui Huang, Lyuzhi Ren, et al.
Nucleic Acids Research
|
March 9, 2013
Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells
Jiehua Zhou, Katrin Tiemann, Pritsana Chomchan, et al.
Molecular Therapy. Nucleic Acids
|
September 24, 2019
Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC
Sorah Yoon, Kai-Wen Huang, Pinelopi Andrikakou, et al.
American Journal of Physiology. Renal Physiology
|
June 20, 2008
Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes
Hang Yuan, Linda Lanting, Zhong-Gao Xu, et al.
Angewandte Chemie (International Ed. in English)
|
April 7, 2025
New Transferrin Receptor-Targeting Conjugate Effectively Delivers DNA to Mouse Brain
Min-Sun Song, Adrian H Bustos, Lise Bastue, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 21, 2012
Functional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a chemically synthesized aptamer with a sticky bridge
Jiehua Zhou, C Preston Neff, Piotr Swiderski, et al.
Molecular Therapy. Nucleic Acids
|
February 22, 2024
Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3
Jeremy Hall, Zhuoran Zhang, Supriyo Bhattacharya, et al.
Biorxiv : the Preprint Server for Biology
|
August 14, 2023
Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3
Jeremy Hall, Zhuoran Zhang, Dongfang Wang, et al.
Science Translational Medicine
|
January 21, 2011
An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice
Charles Preston Neff, Jiehua Zhou, Leila Remling, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 50) with videos related to
Sort By:
Page
of 5
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 30, 2025
C/EBPβ stabilizes oxidative stress in triple-negative breast cancer cells, driving taxane resistance and immune evasion
Kevin Holm, Min-Sun Song, L Z Samara, et al.
Molecular Therapy. Nucleic Acids
|
December 2, 2024
Local CpG-<i>Stat3</i> siRNA treatment improves antitumor effects of immune checkpoint inhibitors
Chunyan Zhang, Rui Huang, Lyuzhi Ren, et al.
Nucleic Acids Research
|
March 9, 2013
Dual functional BAFF receptor aptamers inhibit ligand-induced proliferation and deliver siRNAs to NHL cells
Jiehua Zhou, Katrin Tiemann, Pritsana Chomchan, et al.
Molecular Therapy. Nucleic Acids
|
September 24, 2019
Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC
Sorah Yoon, Kai-Wen Huang, Pinelopi Andrikakou, et al.
American Journal of Physiology. Renal Physiology
|
June 20, 2008
Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes
Hang Yuan, Linda Lanting, Zhong-Gao Xu, et al.
Angewandte Chemie (International Ed. in English)
|
April 7, 2025
New Transferrin Receptor-Targeting Conjugate Effectively Delivers DNA to Mouse Brain
Min-Sun Song, Adrian H Bustos, Lise Bastue, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
November 21, 2012
Functional in vivo delivery of multiplexed anti-HIV-1 siRNAs via a chemically synthesized aptamer with a sticky bridge
Jiehua Zhou, C Preston Neff, Piotr Swiderski, et al.
Molecular Therapy. Nucleic Acids
|
February 22, 2024
Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3
Jeremy Hall, Zhuoran Zhang, Supriyo Bhattacharya, et al.
Biorxiv : the Preprint Server for Biology
|
August 14, 2023
Oligo-PROTAC strategy for cell-selective and targeted degradation of activated STAT3
Jeremy Hall, Zhuoran Zhang, Dongfang Wang, et al.
Science Translational Medicine
|
January 21, 2011
An aptamer-siRNA chimera suppresses HIV-1 viral loads and protects from helper CD4(+) T cell decline in humanized mice
Charles Preston Neff, Jiehua Zhou, Leila Remling, et al.
Page
of 5